Are BRCA1 and BRCA2 gene mutation patients underscreened for pancreatic adenocarcinoma?

Volume: 119, Issue: 6, Pages: 777 - 783
Published: Jan 12, 2019
Abstract
Breast cancer (BRCA) mutations account for the highest proportion of hereditary causes of pancreatic ductal adenocarcinoma (PDAC). Screening is currently recommended only for patients with one first-degree relative or two family members with PDAC. We hypothesized that screening all BRCA1/2 patients would identify a higher rate of pancreatic abnormalities.All BRCA1/2 patients at a single academic center were retrospectively reviewed (2005-2015)....
Paper Details
Title
Are BRCA1 and BRCA2 gene mutation patients underscreened for pancreatic adenocarcinoma?
Published Date
Jan 12, 2019
Volume
119
Issue
6
Pages
777 - 783
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.